Komori
Earnings2206Ezaki Glico Co.,Ltd.Food

Summary of Financial Results for the First Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)

In the first quarter of the fiscal year ending December 2026, net sales increased 10.3% year on year and operating income increased 40.7%, resulting in higher sales and higher profit. The full-year earnings forecasts and annual dividend forecast remain unchanged from the previous forecasts.

Worth reading
47Recurring
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
1068
¥ millions (year-on-year change in operating income)
Wording
Conditional
How definitive the wording is.

Results for this period

First quarter1 January 2026–31 March 2026ConsolidatedJapanese GAAP
Net Sales85,277¥ millionYear on year +10.3%Progress 22.4%
Operating profit3,697¥ millionYear on year +40.7%Progress 26.4%
Ordinary income4,958¥ millionYear on year +35.5%Progress 29.2%
Net income attributable to owners of the parent3,583¥ millionYear on year +46.0%Progress 35.8%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥56.45
Financial position at period-end
Total assets383,827¥ million
of which net assets 277,056 ¥ millionEquity ratio 72.0%vs. prior year-end +1.5pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueHealth and Food Business ¥8,887 million (YoY +6.1%), Dairy Business ¥14,201 million (YoY +2.9%), Nutritional Confectionery Business ¥15,452 million (YoY +2.6%), Food Ingredients Business ¥2,775 million (YoY -2.4%), Domestic Other Businesses ¥17,513 million (YoY +6.7%), Overseas Operations ¥26,447 million (YoY +26.9%)
Segment profitHealth and Food Business ¥-1,290 million, Dairy Business ¥-2,305 million, Nutritional Confectionery Business ¥794 million (YoY -30.0%), Food Ingredients Business ¥489 million (YoY +20.3%), Domestic Other Businesses ¥-1 million, Overseas Operations ¥4,807 million (YoY +46.7%)
Regional sales717 Millions of yuan (YoY +41.2%), 28 USD million (YoY -17.0%), 26 USD million (YoY +9.5%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥380,000 million (YoY +5.1%)
Operating profit¥14,000 million (YoY +60.2%)
Ordinary income¥17,000 million (YoY +46.0%)
Net income¥10,000 million (YoY +98.5%)
Annual Dividend Forecast¥95 → ¥95(0.0%)
Factors Behind Changes in Business Performance

The factors affecting the change in operating income were an increase of ¥3,790 million due to changes in net sales, a decrease of ¥2,765 million due to changes in raw material prices, an increase of ¥395 million due to other changes in costs, an increase of ¥808 million due to changes in the freight and warehousing expense ratio, a decrease of ¥349 million due to changes in sales promotion and advertising expenses, and a decrease of ¥810 million due to changes in general and administrative expenses.

Disclosure regarding the going concern assumption

No applicable matters.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Name of newly added company Not disclosed / Excluded Company Name Not disclosed
Impairment lossNo applicable matters.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥464 million, Gain on changes in equity interests ¥39 million / Extraordinary loss No applicable matters.
Depreciation and amortization¥4,764 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingNo
Issued Shares at Period-End68,468,569 Shares
Treasury Shares at Period-End5,323,018 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationFirst quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 January 2026–31 March 2026
Net Sales¥85,277 million (YoY +10.3%)
Operating profit¥3,697 million (YoY +40.7%)
Ordinary income¥4,958 million (YoY +35.5%)
Profit attributable to owners of the parent¥3,583 million (YoY +46.0%)
Net income per share¥56.45
Equity ratioEnd of the current fiscal period 72 / End of previous period 70.5
Total assets¥383,827 million
Net assets¥277,056 million
Full-year earnings forecastNet Sales ¥380,000 million (YoY +5.1%) / Operating profit ¥14,000 million (YoY +60.2%) / Ordinary income ¥17,000 million (YoY +46.0%) / Net income ¥10,000 million (YoY +98.5%)
Annual Dividend Forecast¥95 → ¥95(0.0%)
Segment revenueHealth and Food Business ¥8,887 million (YoY +6.1%), Dairy Business ¥14,201 million (YoY +2.9%), Nutritional Confectionery Business ¥15,452 million (YoY +2.6%), Food Ingredients Business ¥2,775 million (YoY -2.4%), Domestic Other Businesses ¥17,513 million (YoY +6.7%), Overseas Operations ¥26,447 million (YoY +26.9%)
Segment profitHealth and Food Business ¥-1,290 million, Dairy Business ¥-2,305 million, Nutritional Confectionery Business ¥794 million (YoY -30.0%), Food Ingredients Business ¥489 million (YoY +20.3%), Domestic Other Businesses ¥-1 million, Overseas Operations ¥4,807 million (YoY +46.7%)
Regional sales717 Millions of yuan (YoY +41.2%), 28 USD million (YoY -17.0%), 26 USD million (YoY +9.5%)
Depreciation and amortization¥4,764 million
Impairment lossNo applicable matters.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥464 million, Gain on changes in equity interests ¥39 million / Extraordinary loss No applicable matters.
Disclosure regarding the going concern assumptionNo applicable matters.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 / Excluded 0 / Name of newly added company Not disclosed / Excluded Company Name Not disclosed
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingNo
Issued Shares at Period-End68,468,569 Shares
Treasury Shares at Period-End5,323,018 Shares
Factors Behind Changes in Business PerformanceThe factors affecting the change in operating income were an increase of ¥3,790 million due to changes in net sales, a decrease of ¥2,765 million due to changes in raw material prices, an increase of ¥395 million due to other changes in costs, an increase of ¥808 million due to changes in the freight and warehousing expense ratio, a decrease of ¥349 million due to changes in sales promotion and advertising expenses, and a decrease of ¥810 million due to changes in general and administrative expenses.
Items this document does not state (10)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyOrders received and order backlogMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue increased in the Health and Food Business, Domestic Other Businesses and Overseas Business, among others. In terms of profit, gross profit increased due in part to higher revenue in China within the Overseas Business, and an improvement in the freight and warehousing expense ratio also contributed to higher profit. These factors were partly offset by higher raw material prices and increases in sales promotion expenses and general and administrative expenses.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the First Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated) | Ezaki Glico Co.,Ltd. (2206) timely disclosure | Komori